Company profile: Lightcast
1.1 - Company Overview
Company description
- Provider of a droplet-based microfluidics and oEWOD platform for parallel and sequential single-cell assays, live-cell recovery for downstream applications, and multi-step workflows that streamline lead identification and optimization in drug discovery, supporting basic and translational research on cell-to-cell communication, immune function, and the impact of CRISPR edits.
Products and services
- Drug Discovery: Workflow-optimized programs leverage multi-step, single-cell assays to streamline lead identification and optimization, delivering functional analysis to support decision-making during discovery campaigns
- Microfluidic Platform: Custom-engineered droplet-based microfluidics with optical electrowetting-on-dielectric (oEWOD) manipulates single cells, enabling massively parallel and sequential assays for functional analysis on one integrated platform
- Single-cell Assays: High-throughput assays execute massively parallel and sequential functional analysis, isolating individual cells in droplets to interrogate behavior and responses across large experiments on Lightcast
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lightcast
Altasciences
HQ: Canada
Website
- Description: Provider of early phase contract research services for pharmaceutical and biotechnology companies, including preclinical safety testing; Phase I–II clinical pharmacology; bioanalysis from preclinical to Phase IV (LC-MS/MS and ligand binding assays); formulation, manufacturing, and analytical services; specialized renal and hepatic impairment studies via external partners; and cardiac safety assessment including QT prolongation evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altasciences company profile →
Bioceros
HQ: The Netherlands
Website
- Description: Provider of biopharmaceutical R&D contract services spanning discovery research to pre-clinical development, including assay development and quantification, molecular and cell biology, and services related to preclinical development of monoclonal antibodies and generation of protein-producing cell lines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioceros company profile →
Phaxiam Therapeutics
HQ: France
Website
- Description: Provider of bacteriophage-based therapies to combat antimicrobial-resistant bacterial infections, offering phage treatments, GMP individualized phage therapies (IPT), standardized phage therapies medicinal products (PTMP), a phage portfolio targeting Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, an in vitro Phagogram test for phage susceptibility, and PhagoDAIR clinical trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phaxiam Therapeutics company profile →
Cambrian Bio
HQ: United States
Website
- Description: Provider of therapeutics to lengthen healthspan via a Distributed Development Company model, advancing programs targeting biological drivers of aging, including ATX-304 (a pan-AMPK activator for cardiometabolic diseases, Phase 1B), Tornado Therapeutics (developing mTOR inhibitors with novel selectivity profiles), and Telovance (a protein complex to enhance ex-vivo cell therapy expansion).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambrian Bio company profile →
Quartesian
HQ: United States
Website
- Description: Provider of biostatistics, programming, and medical writing services, delivering customized, insightful data to organizations performing clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quartesian company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lightcast
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lightcast
2.2 - Growth funds investing in similar companies to Lightcast
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lightcast
4.2 - Public trading comparable groups for Lightcast
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →